Dr Ken Dutton-Regester is a cancer researcher at the QIMR Berghofer Medical Research Institute, where he explores new ways to treat late-stage melanoma.
After completing his PhD at the Queensland University of Technology in 2012, Dr Dutton-Regester was awarded an NHMRC Early Career Fellowship to learn genome-wide functional approaches at the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute. Dr Dutton-Regester is an AMP Tomorrow Fund Fellow, and a Young Investigator on the Melanoma Research Alliance Team Science Award. Previously, he was chair of the Associate Member Council for the American Association for Cancer Research, and an AMP Foundation Tomorrow Maker.
Besides his research, Dr Dutton-Regester is passionate about science communication. A national finalist in Fame Lab and a Queensland Young Tall Poppy Scientist Awardee in 2017, Dr Dutton-Regester speaks at a variety of events to various audiences. In 2019, Dr Dutton-Regester founded Excite Science. A profit-for-purpose start-up creating fun, portable exhibits and activities that educate the community on complex diseases. The first project of Excite Science was to create the world’s first cancer-biology-themed puzzle/escape room as a unique way to educate people about cancer.